Skip to main content
. 2018 Feb 21;18(2):1–160.

Table A29:

Net Budget Impact of Funding Continuous Glucose Monitoring in Ontario—Scenario 3, Conservative Projection of a 20% Annual Increase, Device Cost Reduction by 30%, 20%, and 10%

Intervention Total Budget Impact
Year 1 Year 2 Year 3 Year 4 Year 5
CGM Device Cost
CGM $24,229,379 $29,075,255 $34,890,306 $41,868,368 $50,242,041
SMBG $10,565,739 $12,678,887 $15,214,665 $18,257,598 $21,909,117
NBI $13,663,640 $16,396,368 $19,675,642 $23,610,770 $28,332,924
CMG Device Cost + 75% Funding of Sensor Costs
CGM $21,962,668 $26,355,201 $31,626,241 $37,951,490 $45,541,787
SMBG $10,565,739 $12,678,887 $15,214,665 $18,257,598 $21,909,117
NBI $11,396,928 $13,676,314 $16,411,577 $19,693,892 $23,632,670
CGM Device Cost Reduction of 30%
CGM $16,960,566 $20,352,679 $24,423,214 $29,307,857 $35,169,429
SMBG $10,565,739 $12,678,887 $15,214,665 $18,257,598 $21,909,117
NBI $6,394,826 $7,673,791 $9,208,550 $11,050,260 $13,260,312
CGM Device Cost Reduction of 20%
CGM $19,383,504 $23,260,204 $27,912,245 $33,494,694 $40,193,633
SMBG $10,565,739 $12,678,887 $15,214,665 $18,257,598 $21,909,117
NBI $8,817,764 $10,581,317 $12,697,580 $15,237,096 $18,284,516
CGM Device Cost Reduction of 10%
CGM $21,806,441 $26,167,730 $31,401,276 $37,681,531 $45,217,837
SMBG $10,565,739 $12,678,887 $15,214,665 $18,257,598 $21,909,117
NBI $11,240,702 $13,488,843 $16,186,611 $19,423,933 $23,308,720

Abbreviations: CGM, continuous glucose monitoring; NBI, net budget impact; SMBG, self-monitoring of blood glucose.